These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The influence of sympathomimetic amines, monoamine oxidase inhibitors, and antihypertensives upon the energy metabolism in the rat heart. Hilliard WG; Oliver WT; Van Petten GR Can J Physiol Pharmacol; 1966 Jul; 44(4):605-13. PubMed ID: 5968213 [No Abstract] [Full Text] [Related]
7. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo. Robinson DS; Lovenberg W; Keiser H; Sjoerdsma A Biochem Pharmacol; 1968 Jan; 17(1):109-19. PubMed ID: 4384242 [No Abstract] [Full Text] [Related]
8. Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats. Stanton HC; Schwartz A Proc West Pharmacol Soc; 1966; 9():6-8. PubMed ID: 4381147 [No Abstract] [Full Text] [Related]
9. Effect of pretreatment with monoamine oxidase inhibitors or (+)-amphetamine on leptazol convulsions in mice and rats. Turner TA; Spencer PS J Pharm Pharmacol; 1968 Dec; 20():Suppl:122S+. PubMed ID: 4388144 [No Abstract] [Full Text] [Related]
10. INHIBITION OF MONOAMINE OXIDASE ACTION ON KYNURAMINE BY SUBSTRATE AMINES AND STEREOISOMERIC ALPHA-METHYL AMINES. FULLER RW; WALTERS CP Biochem Pharmacol; 1965 Feb; 14():159-63. PubMed ID: 14332461 [No Abstract] [Full Text] [Related]
11. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines. Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601 [No Abstract] [Full Text] [Related]
12. [Apropos of the mechanism of action of monoamine oxidase-inhibitors on the coronary circulation]. Mirzoian RS Farmakol Toksikol; 1965; 28(1):51-5. PubMed ID: 5845043 [No Abstract] [Full Text] [Related]
13. Effect of monoamine oxidase inhibitors on qualitative alterations in enzymatic properties of mitochondrial monoamine oxidases. Abdel Samed MH; Akopyan ZI; Veryovkina IV; Kulygina AA; Gorkin VZ Biochem Pharmacol; 1971 Oct; 20(10):2571-7. PubMed ID: 5114498 [No Abstract] [Full Text] [Related]
14. Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patterns. Collins GG; Youdim MB; Sandler M Biochem Pharmacol; 1972 Jul; 21(14):1995-8. PubMed ID: 4405452 [No Abstract] [Full Text] [Related]
15. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy. Hendley ED; Snyder SH Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350 [No Abstract] [Full Text] [Related]
16. VOLATILE AMINE OXIDASE INHIBITOR FROM HYDRAZINE DERIVATIVES. KORY M; MINGIOLI E Biochem Pharmacol; 1964 Apr; 13():577-88. PubMed ID: 14191864 [No Abstract] [Full Text] [Related]
17. Selective brain monoamine oxidase inhibition resulting from an interaction between reversible and irreversible inhibitors. Horita A Int J Neuropharmacol; 1965 Nov; 4(6):337-42. PubMed ID: 4379937 [No Abstract] [Full Text] [Related]
18. Effect of monoamine oxidase inhibitors on the N-demethylation and hydrolysis of meperidine. Eade NR; Renton KW Biochem Pharmacol; 1970 Jul; 19(7):2243-50. PubMed ID: 5520372 [No Abstract] [Full Text] [Related]
19. CHEESE AND MONOAMINE OXIDASE INHIBITORS. INTERACTION IN ANAESTHETISED CATS. NATOFF IL Lancet; 1964 Mar; 1(7332):532-3. PubMed ID: 14100189 [No Abstract] [Full Text] [Related]
20. Tachyphylaxis. VI. Amphetamine in the isolated rabbit aortic strip. Maengwyn-Davies GD; Cowan FF; Koppanyi T Arch Int Pharmacodyn Ther; 1966 Apr; 160(2):454-72. PubMed ID: 5954039 [No Abstract] [Full Text] [Related] [Next] [New Search]